Validation of a point-of-care finger-prick approach to aspartate aminotransferase-to-platelet ratio index and fibrosis-4 testing: a paired-comparison study
Research Connections · 05.10.2026 · 1 (4)
DOI: 10.1093/rescon/vmag198 ↗Kurz gefasst
Fachartikel in der Zeitschrift Research Connections, online erschienen am 30.10.2026. Verfasst von David Smookler und 9 weiteren Autor:innen. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Viral Hepatitis Care Network.
Abstract (Originalsprache)
Same-day treatment models for hepatitis C virus infection (HCV) use on-site assessment of liver fibrosis to determine eligibility for the appropriate treatment pathway. We investigated a finger-prick, point-of-care (POC-FP) platform for blood analysis of fibrosis, evaluating the analytical agreement with standard-of-care (SOC) laboratory machines requiring venipuncture. This paired-comparison study recruited liver clinic patients with a range of fibrosis due to mixed aetiology. Platelets, AST, and ALT were measured by: (i) hospital core laboratory (SOC); and benchtop analyzers, using (ii) venous (POC-V), or (iii) finger-prick (POC-FP) blood. Aspartate aminotransferase to platelet ratio index (APRI) and Fibrosis-4 (FIB-4) were calculated from each arm, allowing differences to be attributed to sample type or analyzer. Sixty participants (32 female, mean age 54.4 years) had paired datasets. POC-FP versus SOC was the primary comparison. Measurements correlated strongly across all analytes (ALT r = 0.96; AST r = 0.93; platelets r = 0.95). Mean differences were small clinically, though statistically significant for AST (+4 U/l, P < .001) and platelets (−28 × 109/l, P < .001); ALT difference was negligible (−1 U/l, P = .3). POC-FP APRI and FIB-4 were modestly elevated (APRI 1.08 vs 0.97, P = .01; FIB-4 3.66 vs 2.94, P < .001) compared to SOC. Reliability was excellent for APRI (ICC 0.96; 95% CI 0.92–0.97). The FIB-4 ICC was 0.91 (95% CI 0.72–0.96), with a confidence interval spanning moderate to excellent reliability. APRI zones matched in 56 of 60 pairs (κ = 0.86 unweighted, 0.93 weighted) and FIB-4 zones in 47 of 60 (κ = 0.68 unweighted, 0.85 weighted). POC analysis took under 15 min. Finger-prick POC results for APRI and FIB-4 closely track SOC in this evaluation of analytical agreement. Combined with rapid HCV diagnostics, this approach could eliminate venipuncture when assessing liver fibrosis. This model merits further evaluation as it has the potential to reduce a remaining barrier to same-day treatment for HCV.
Förderung
- Viral Hepatitis Care Network
Zitieren
APA
Smookler, D., Vanderhoff, A., Tran, S. S., Barber, B., Kuczynski, M., Saunthar, A., Mendlowitz, A., Biondi, M., Capraru, C., & Feld, J. J. (2026). Validation of a point-of-care finger-prick approach to aspartate aminotransferase-to-platelet ratio index and fibrosis-4 testing: a paired-comparison study. Research Connections, 1(4). https://doi.org/10.1093/rescon/vmag198
Vancouver
Smookler D, Vanderhoff A, Tran SS, Barber B, Kuczynski M, Saunthar A, et al. Validation of a point-of-care finger-prick approach to aspartate aminotransferase-to-platelet ratio index and fibrosis-4 testing: a paired-comparison study. Research Connections. 2026;1(4). doi:10.1093/rescon/vmag198
BibTeX
@article{Smookler2026,
author = {Smookler, David and Vanderhoff, Aaron and Tran, Sarah S and Barber, Bethany and Kuczynski, Magdalena and Saunthar, Ahreni and Mendlowitz, Andrew and Biondi, Mia and Capraru, Camelia and Feld, Jordan J},
title = {Validation of a point-of-care finger-prick approach to aspartate aminotransferase-to-platelet ratio index and fibrosis-4 testing: a paired-comparison study},
journal = {Research Connections},
year = {2026},
volume = {1},
number = {4},
doi = {10.1093/rescon/vmag198}
}
EUVIMED